CLINICAL_TRIALS
trial_result
· 2014-10-07
Clinical Trial Update: A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes [Phase 1]
Summary
Phase 1 study evaluating LY2189265 in combination with sitagliptin in participants with Type 2 diabetes; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-10-07